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Aprataxin and polynucleotide kinase (PNK) are DNA end processing factors that are recruited into the DNA
single- and double-strand break repair machinery through phosphorylation-specific interactions with XRCC1
and XRCC4, respectively. These interactions are mediated through a divergent class of forkhead-associated
(FHA) domain that binds to peptide sequences in XRCC1 and XRCC4 that are phosphorylated by casein
kinase 2 (CK2). Here, we identify the product of the uncharacterized open reading frame C2orf13 as a novel
member of this FHA domain family of proteins and we denote this protein APLF (aprataxin- and PNK-like
factor). We show that APLF interacts with XRCC1 in vivo and in vitro in a manner that is stimulated by CK2.
Yeast two-hybrid analyses suggest that APLF also interacts with the double-strand break repair proteins
XRCC4 and XRCC5 (Ku86). We also show that endogenous and yellow fluorescent protein-tagged APLF
accumulates at sites of H2O2 or UVA laser-induced chromosomal DNA damage and that this is achieved
through at least two mechanisms: one that requires the FHA domain-mediated interaction with XRCC1 and
a second that is independent of XRCC1 but requires a novel type of zinc finger motif located at the C terminus
of APLF. Finally, we demonstrate that APLF is phosphorylated in a DNA damage- and ATM-dependent
manner and that the depletion of APLF from noncycling human SH-SY5Y neuroblastoma cells reduces rates
of chromosomal DNA strand break repair following ionizing radiation. These data identify APLF as a novel
component of the cellular response to DNA strand breaks in human cells.
DNA single- and double-strand breaks are induced through
a variety of ways, including the direct attack of deoxyribose by
reactive oxygen species. DNA strand breaks can pose a con-
siderable threat if not rapidly repaired or responded to appro-
priately, as indicated by the increased genetic instability, can-
cer frequency, or neurodegenerative pathology observed in
diseases in which such processes are absent or attenuated.
While the overall mechanisms by which DNA single- and dou-
ble-strand breaks are repaired are very different, the repair of
all such strand breaks requires a number of common enzymatic
steps (7). For example, most DNA breaks arising endog-
enously in cells require end processing activities to restore
damaged DNA termini to 3 hydroxyl and 5 phosphate con-
figurations, and in the final repair step, all DNA breaks require
a DNA ligase to reestablish the integrity of the phosphodiester
backbone.
DNA end processing is perhaps the most enzymatically di-
verse step of DNA strand break repair, primarily because of
the broad range of termini that can arise. One enzyme impli-
cated in the repair of oxidative DNA termini at both DNA
single- and double-strand breaks is polynucleotide kinase
(PNK) (10, 33). PNK associates with the DNA single-strand
break repair (SSBR) and double-strand break repair (DSBR)
protein complexes through direct interaction with casein ki-
nase 2 (CK2)-phosphorylated XRCC1 and XRCC4, respec-
tively (16, 21). These interactions are mediated through a di-
vergent forkhead-associated (FHA) domain in PNK that can
specifically target CK2-phosphorylated peptides. Intriguingly,
the protein aprataxin, which is mutated in the neurodegenera-
tive disease ataxia-oculomotor apraxia type 1, possesses a
similar FHA domain and binds the same CK2-phosphory-
lated regions of XRCC1 and XRCC4 (6, 11, 12–14, 22, 25).
Aprataxin is also an end processing enzyme, repairing abortive
5 AMP intermediates of DNA ligase activity (1). In the
current study, we identify a third member of the aprataxin-
and PNK-like FHA domain family which we denote APLF
(aprataxin- and PNK-like factor). We demonstrate that APLF is
a novel component of the cellular response to chromosomal
DNA single- and double-strand breaks.
MATERIALS AND METHODS
DNA constructs and recombinant proteins. To create pGBKT7-APLF, the
human APLF open reading frame (ORF) was amplified from the C2orf13
IMAGE clone 6042653 (MRC GeneService) by PCR using the primers 5-AAAA
CCATGGCAATGTCCGGGGGCTTCGAGCTG-3 (the NcoI site and the
APLF start codon are underlined) and 5-TTGAATTCGGCAGATATGACTA
CAGAA-3 (the EcoRI site and the stop codon are underlined) and subcloned
into the NcoI/EcoRI sites of pGBKT7 (Clontech). To create pcD2E-His-Myc-
APLF, the APLF ORF was amplified from IMAGE clone 6042653 by PCR using
the primers 5-AAAGAATTCCCGCCATGCATCACCATCACCATCACCCGG
AGGAGCAGAAGCTGATCTCAGAGGAGGACCTGTCCGGGGGCTTCGA
GCTGCAG-3 (the EcoRI site and the APLF start codon are underlined, and
the His6 and Myc tags are italicized) and 5-AAAGAATTCGGATTCCTATTT
TCTTTTCATAAACC-3 (the EcoRI site and the stop codon are underlined)
and subcloned into the EcoRI sites of the mammalian expression vector pcD2E
(15). To create pET16b-APLF, a fragment encoding APLF was removed from
pGBKT7-APLF and subcloned into pET16b (Novagen) by using NdeI and
BamHI. To create pET16b-APLF1-166, pET16b-APLF was linearized with AvrII
and the 5 overhangs filled in with Klenow polymerase prior to religation.
pET16b-APLF1-166 encodes a polypeptide of 168 amino acids, of which 166
* Corresponding author. Mailing address: Genome Damage and
Stability Centre, University of Sussex, Falmer, Brighton, Sussex BN1
9RQ, United Kingdom. Phone: 44 (0) 1273 877519. Fax: 44 (0) 1273
678121. E-mail: k.w.caldecott@sussex.ac.uk.
† These authors contributed equally to this work.












encode the amino-terminal region of APLF. To create pET16b-APLF360-511,
pET16b-APLF was cut with SphI and the resulting 3 overhang filled in with
Klenow fragment. A 0.5-kb fragment encoding the C-terminal region of APLF
was then released with BamHI and subcloned into the blunted NdeI/BamHI sites
of pET16b. To create pEYFP-C1-APLF, the APLF ORF was amplified from
IMAGE clone 6042653 by PCR using the primers 5-AAAGAATTCCATGTC
CGGGGGCTTCGAGCTG-3 (the EcoRI site and the APLF start codon are
underlined) and 5-AAAGAATTCGGATTCCTATTTTCTTTTCATAAAC
C-3 (the EcoRI site and the stop codon are underlined) and subcloned into the
EcoRI sites of pEYFP-C1 (Clontech). To create pEYFP-C1-APLFR27A,
pEYFP-C1-APLFzfm1, and pEYFP-C1-APLFzfm2, the APLF ORF in pEYFP-
C1-APLF was mutated by site-directed mutagenesis using a QuikChange mu-
tagenesis kit and the appropriate primers (Stratagene). To create pEYFP-nls-
APLF, pEYFP-nls-APLFR27A, and pEYFP-nls-APLFzfm1, the simian virus 40
(SV40) large T-antigen nuclear localization signal was engineered into the rel-
evant fusion protein between the APLF sequence and its N-terminal yellow
fluorescent protein (YFP) tag by subcloning the annealed oligonucleotides 5-T
CGAGCCCCTAAGAAAAAGCGGAAGGTGCA-3 and 5-AGCTTGCACC
TTCCGCTTTTTCTTAGGGGC-3 into the XhoI/HindIII sites within the mul-
tiple cloning site of the appropriate pEYFP-C1-APLF construct.
To create pRFP-C1-XRCC1, the XRCC1 ORF was amplified from pcD2EXH
(8) by PCR using the primers 5-AAGAATTCTATGCCGGAGATCCGCCTC
CGCC-3 (the EcoRI site and the XRCC1 start codon are underlined) and
5-TTGTCGACTCAGGCTTGCGGCACCACCCCATAGAG-3 (the SalI site
and the stop codon are underlined) and subcloned into the EcoRI/SalI sites of
pRFP-C1 encoding monomeric red fluorescent protein (mRFP) (9). To create
pRFP-C1-XRCC4, the XRCC4 ORF was subcloned from pCI-neo-Myc-XRCC4
(kindly provided by Queti Riballo and Elaine Taylor) into pRFP-C1 by using
EcoRI and XbaI. All recombinant histidine-tagged proteins expressed in Esch-
erichia coli were expressed in BL21(DE3) and purified by metal chelate affinity
chromatography using nickel-nitrilotriacetic acid agarose (QIAGEN).
Protein slot blots and far-Western blotting. Recombinant XRCC1-His (10 g)
expressed in and purified from bacteria (see above) was phosphorylated with
CK2 in 90-l reaction mixtures containing 10 mM MgCl2, 1 mM ATP, 13.3 mM
HEPES, pH 8, 80 mM NaCl, and 0.67 mM dithiothreitol (DTT) at 30°C for 30
min. Mock phosphorylation reactions lacked CK2 or XRCC1, as indicated. For
slot blot experiments, mock phosphorylation reactions and aliquots of CK2
phosphorylation reactions (0.125 to 1 g of XRCC1-His as indicated) were slot
blotted under a vacuum, in quadruplicate, onto Hybond-C nitrocellulose mem-
branes. The membranes were air dried and one strip stained with amido black.
The remainder were blocked in binding buffer (20 mM HEPES, 50 mM NaCl, 1
mM DTT) containing 2% (wt/vol) nonfat dried milk (NFDM) at room temper-
ature for 4 h. Blots were then washed (three times for 5 min each) with binding
buffer lacking NFDM and incubated with 5 g of full-length recombinant His-
APLF, His-APLF1-166, or His-APLF360-511 in binding buffer at 4°C overnight.
Blots were then washed (three times for 5 min each) in binding buffer and
incubated in binding buffer containing 2% NFDM and affinity-purified anti-
APLF polyclonal antibody (SK3595) at a dilution of 1 in 500 at room tempera-
ture for 4 h. The blots were then washed (three times for 10 min each) in binding
buffer and incubated in binding buffer containing 2% NFDM and goat anti-rabbit
horseradish peroxidase-conjugated secondary antibody at a dilution of 1 in 5,000
at room temperature for 1 h. Finally, following further washes in binding buffer
(three 5-min washes), antibody complexes were detected by enhanced chemilu-
minescence (ECL Plus; Amersham Biosciences) and autoradiography. SK3595
was raised by Eurogentec and affinity purified against recombinant human APLF
expressed and purified from E. coli.
For far-Western blotting, 3 g of full-length recombinant His-APLF, His-
APLF1-166, or His-APLF360-511 was fractionated in quadruplicate by sodium
dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) and trans-
ferred to a Hybond-C nitrocellulose membrane. The membrane was stained with
Ponceau S to confirm equal loading and transfer and then destained. Proteins
were denatured and renatured by sequential incubations (10 min each) with
decreasing concentrations (6 M to 0.19 M) of guanidine-HCl essentially as
described previously (23). Membranes were then incubated at 4°C overnight with
2 ml 1% NFDM-HYB100 containing recombinant XRCC1-His (10 g) prephos-
phorylated in 90-l reaction mixtures (at 30°C for 30 min) containing 10 mM
MgCl2, 1 mM ATP, 13.3 mM HEPES, pH 8, 80 mM NaCl, 0.67 mM DTT, and
rat liver CK2 (kindly provided by Flavio Meggio and Lorenzo Pinna). Mock
phosphorylation reactions lacked CK2 or XRCC1-His, as indicated. Filters were
then washed with 1% NFDM-HYB100 and the membranes incubated with
anti-XRCC1 polyclonal antibody (SK3188) at a dilution of 1 in 1,000 in 1%
NFDM-HYB100 at room temperature for 2 h. The membranes were then
washed (three times for 10 min each) with 1% NFDM-HYB100 and incubated
with goat anti-rabbit horseradish peroxidase-conjugated secondary antibody at a
dilution of 1 in 5,000 in 1% NFDM-HYB100 at room temperature for 30 min.
Following further washes (three 10-min washes) with 1% NFDM-HYB100, an-
tibody complexes were detected by enhanced chemiluminescence (ECL Plus;
Amersham Biosciences) and autoradiography.
Anti-APLF (SK3595) and anti-XRCC1 (SK3188) polyclonal antibodies were
raised by Eurogentec against recombinant human APLF and XRCC1 from E.
coli and insect cells, respectively, and were affinity purified against the appropri-
ate recombinant proteins from E. coli.
Yeast two-hybrid analyses. Saccharomyces cerevisiae Y190 cells were trans-
formed with the indicated pACT and PGBKT7 constructs and transformants
selected on minimal medium plates (glucose plus yeast nitrogen base without
amino acids) additionally containing adenine and histidine. Pooled populations
of transformants were streaked onto two minimal medium plates with adenine
and histidine and one minimal medium plate with adenine and 50 mM 3-amino-
1,2,4-triazole. The activation of the His3 reporter gene was indicated by com-
parative growth on minimal medium plates containing adenine and 3-amino-
1,2,4-triazole and minimal medium plates containing adenine and histidine after
4 to 6 days at 30°C. The activation of the -galactosidase (-Gal) reporter gene
was determined by qualitative X-Gal (5-bromo-4-chloro-3-indolyl--D-galacto-
pyranoside) assays on colony filter lifts from minimal medium plates containing
adenine and histidine. Quantitative -Gal assays were conducted essentially as
described by Clontech (Yeast Protocols Handbook). Equivalent expression levels
of DNA binding domain or activation domain fusion proteins were confirmed by
Western blotting both for cell cultures employed for filter lift -Gal assays and
for quantitative -Gal assays. Cell extracts were prepared in cracking buffer (8 M
urea, 5% [wt/vol] SDS, 40 mM Tris-HCl [pH 6.8], 0.1 mM EDTA, 0.4 mg/ml
bromophenol blue, 1% -mercaptoethanol, 1 protease inhibitor cocktail
[Sigma]) and fractionated by SDS-PAGE, and Myc-tagged APLF (expressed
from pGBKT7) was detected by immunoblotting with anti-Myc monoclonal
antibody (MAb) (9B11; Cell Signaling Technology) and DNA binding domain
fusion proteins by immunoblotting with polyclonal anti-GAL4 activation domain
antibody (Upstate Biotechnology). Washed membranes were then incubated
with the appropriate horseradish peroxidase-conjugated secondary antibody
(Dako) and bound antibodies visualized using enhanced chemiluminescence
(Amersham Biosciences).
Immunoprecipitations. For immunoprecipitation experiments, 3  107
HeLa cells were transiently transfected with pcD2E vector or pcD2E-His-Myc-
APLF by using GeneJuice transfection reagent (Novagen) and pooled popula-
tions of transfected cells were selected in medium containing G418 (0.8 mg/ml)
for 5 days. Alternatively, 3  107 A549 cells were stably transfected with
pCD2E and either empty pSUPER or pSUPER encoding the APLF RNA
interference (RNAi) sequence GAAGAAATCTGCAAAGATA (pSUPER-
APLF) by selection with 0.8 mg/ml G418 for 4 weeks. Transfected cells were
lysed in 3 ml lysis buffer (20 mM Tris-HCl, pH 7.5, 10 mM EDTA, 100 mM NaCl,
1% Triton X-100, 0.5 mM sodium orthovanadate, 50 mM sodium fluoride, 10
mM -glycerophosphate, and 1 protease inhibitor cocktail [Sigma]) on ice for
5 min. Clarified extracts were diluted to 2 mg/ml in lysis buffer and 3 ml of each
extract precleared for 1 h at 4°C with 60 l protein G-Sepharose beads (Sigma).
HeLa cell extract (1.5 ml) was incubated with 1 l of either anti-Myc MAb
(9B11) or anti-Flag MAb (M2; Sigma) and A549 cell extract (1.5 ml) with either
100 l anti-XRCC1 polyclonal antibody (SK3188) or 0.01 l rabbit immuno-
globulin G (IgG; Dako) overnight at 4°C with gentle agitation. Each sample was
then incubated with 30 l protein G-Sepharose beads for 1 h at 4°C with gentle
agitation. The beads were then washed three times with lysis buffer (300 l each
wash) and bound proteins eluted by heating with 55 l of 2 SDS-PAGE sample
buffer at 90°C for 5 min. Clarified protein samples were fractionated by SDS-
PAGE, transferred to nitrocellulose, and immunoblotted with anti-Myc MAb
(9B11) or either anti-XRCC1 (SK3188) or anti-APLF (SK3595) polyclonal an-
tibody.
Direct and indirect immunofluorescence experiments. For direct immunoflu-
orescence experiments, XRCC1 mutant EM9 (30, 31) or XRCC4 mutant XR-1
(20, 28) CHO cells seeded onto coverslips were transfected with the indicated
enhanced YFP or mRFP fusion protein constructs by using GeneJuice transfec-
tion reagent (Novagen). After 24 h, cells were washed with phosphate-buffered
saline (PBS) and mock treated or treated with 10 mM hydrogen peroxide in PBS
for 10 min at room temperature, washed with PBS, and then incubated in
drug-free media at 37°C for 20 to 120 min. The coverslips were then washed in
PBS and fixed (5 min in 4% paraformaldehyde in PBS). Fixed cells were then
permeabilized in 0.2% Triton X-100 for 2 min, washed with PBS, and stained
with 0.000025% DAPI (4,6-diamidino-2-phenylindole) for 5 min. Coverslips
were mounted in Vectashield (Vector Labs) and analyzed with a Zeiss Axioplan
2 fluorescence microscope. Photographs were taken at a magnification of 100
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and YFP-APLF-transfected cells scored for subcellular localization of YFP-
APLF.
For indirect immunofluorescence experiments, A549 cells were seeded onto
gridded coverslips (MatTek) in 10-cm dishes at 1  104 cells/cm2 and, after 2
days, preincubated for 10 min with 10 g/ml Hoechst dye 33258 at 37°C. Selected
cells were then irradiated with a 351-nm UVA laser focused through a 40/
1.2-W objective using a Zeiss Axiovert equipped with LSM 520 Meta. UVA
(10.47 J) was introduced to an area of approximately 15 m by 2 m (approx-
imately 0.35 J/m2). After exposure, coverslips were incubated at 37°C for the
times indicated and washed in ice-cold PBS, and cells were fixed in ice-cold
methanol-acetone (1:1) for 5 min and then permeabilized for 5 min in PBS-0.1%
Tween. Coverslips were incubated in PBS-5% NFDM for 30 min for blocking
and then overnight at 4°C in PBS-1% NFDM containing anti-XRCC1 MAb
(clone 33-2-5) and anti-APLF polyclonal antibody (both at 1/200 dilutions).
Coverslips were then incubated with secondary labeling with Alexa Fluor 555
anti-mouse and Alexa Fluor 488 anti-rabbit antibodies (1/200 in PBS-1% milk;
Invitrogen) for 1 hour at room temperature. DNA was stained with 0.1 g/ml
DAPI (Sigma). Tracks were then visualized using a Nikon Eclipse 50i microscope
fitted with a 100 oil immersion objective.
Chromosomal DNA strand break repair assays. To knock down APLF in
SH-SY5Y cells, 2  106 cells were cotransfected with pCD2E vector (2 g) and
either pMAX-GFP vector (4 g; Amaxa), pSUPER vector harboring the APLF
RNAi sequence GAAGAAATCTGCAAAGATA (4 g), or 160 pg of the
XRCC1 small interfering RNA (siRNA) duplex GCCUGAAGUAUGUGCUA
UAdTdT (sense strand; QIAGEN) by using Nucleofector and Nucleofector kit
V (Amaxa). Twenty-four hours after nucleofection, cells were placed into a mild
selection/differentiation medium containing 0.25 mg/ml G418 and 10 M all-
trans retinoic acid to induce neuronal differentiation. After 3 days of selection,
the medium was replaced with medium containing 10 M retinoic acid only. For
alkaline comet assays, 5  105 SH-SY5Y cells were harvested 6 days after
transfection and irradiated (20 Gy of gamma rays) before being returned to 37°C
for 7.5, 15, or 30 min. At each time point, 1 105 treated cells were removed and
DNA damage was measured by single-cell agarose gel electrophoresis, essentially
as described previously (5). For -H2AX assays, A549 cells stably transfected
with pCD2E and either empty pSUPER or pSUPER encoding the APLF RNAi
sequence GAAGAAATCTGCAAAGATA, or SH-SY5Y cells 6 days after tran-
sient transfection with green fluorescent protein, pSUPER-APLF, or XRCC1
siRNA as described above, were grown on glass coverslips and exposed to 1 to 3
Gy of -radiation before being returned to 37°C. At the times indicated, cover-
slips were washed in PBS, fixed (5 min in 4% paraformaldehyde in PBS), per-
meabilized (0.2% Triton X-100 for 2 min), blocked (5% NFDM for 30 min), and
incubated with anti--H2AX MAb (clone JBW301, 1/800 in 1% NFDM in PBS;
Upstate). Cells were then washed (three times for 5 min each) in PBS containing
0.1% Tween 20 and 0.02% SDS and incubated for 1 h with Alexa Fluor 488 goat
anti-mouse IgG secondary antibody (1/200 dilution in 1% milk-PBS). The cells
were then washed (five times for 5 min each) as described above, mounted in
Vectashield (Vector Labs), and scored for -H2AX foci by using a Nikon Eclipse
50i microscope.
DNA damage-induced modification of APLF. Subconfluent 1BR3, FD105
(AOA1), or AT7BI (A-T) primary fibroblasts were harvested, either exposed to
gamma rays (3 Gy) or treated with 10 mM H2O2 on ice for 20 min, and then
incubated at 37°C for 20 min (H2O2) or 30 min (gamma rays) in drug-free media.
Cells were then harvested and lysed in SDS-PAGE sample buffer, and aliquots of
cell extracts were fractionated by SDS-PAGE (7.5% gels) and immunoblotted
with anti-APLF polyclonal antibody (SK3595).
RESULTS
Database analyses identified a third protein that contains an
FHA domain with sequence similarity to the FHA domains
present in PNK and aprataxin (Fig. 1A). In particular, the
putative FHA domain in this protein, which is the 511-amino-
acid product of the previously uncharacterized ORF C2orf13
(Swiss-Prot accession no. Q8IW19), contains a number of basic
residues that are predicted to promote the interaction with
peptides phosphorylated by CK2 (2, 34). We thus denoted this
protein APLF. BLAST analyses with the human APLF protein
sequence identified putative homologues in a broad range of
organisms from flies to humans and revealed that APLF is
comprised of two highly conserved regions separated by a
poorly conserved central region (Fig. 1B). Whereas the con-
served amino terminus encodes the FHA domain, the con-
served C-terminal region includes two short motifs that are
repeated in tandem and strongly resemble C2H2 zinc fingers
(ZnFs). The C-terminal region also possesses a highly acidic
C-terminal tail. BLAST analyses with the C-terminal region
identified 18 additional proteins that contain the ZnF motif in
a range of organisms, though only in APLF homologues was
the motif present in duplicate (Fig. 1C). The ZnF is highly
conserved both in primary sequence and in the spacing be-
tween the putative zinc coordinating residues and is configured
CX5CX6HX5H. Strikingly, many of the proteins containing the
APLF-like ZnF are involved in DNA strand break repair
and/or contain domains implicated in DNA metabolism, in-
cluding four homologues of tyrosyl phosphodiesterase 1, three
poly(ADP-ribose) polymerase 1-like proteins, and homologues
of DNA ligase III and Ku70.
We first examined whether, like PNK and aprataxin, APLF
interacts with the DNA strand break repair proteins XRCC1
and XRCC4. Indeed, APLF interacted with both of these pro-
teins in yeast two-hybrid analyses but did not interact with
several other DNA strand break repair proteins, including
aprataxin and DNA ligase III (Fig. 2A). We showed previ-
ously that neither XRCC1 nor XRCC4 transactivates the His3
or -Gal reporter genes in these assays by itself (11). In addi-
tion, endogenous XRCC1 was immunoprecipitated from Myc-
APLF-transfected HeLa cell extracts by anti-Myc antibodies
but was not immunoprecipitated by control anti-FLAG anti-
bodies (Fig. 2B, upper panel) or by anti-Myc antibodies from
untransfected cells (Fig. 2B, lower panel). More importantly,
immunoprecipitation of endogenous XRCC1 from the human
A549 cell extract, which we detected using both standard anti-
XRCC1 polyclonal antibodies and antibodies specific for CK2-
phosphorylated XRCC1(pS485/pT488) (21, 22), corecovered
endogenous APLF, confirming that APLF is a bona fide com-
ponent of the single-strand break repair machinery (Fig. 2C,
left panel). That it was APLF that was recovered and detected
in these experiments was confirmed by its absence from A549
cells in which APLF was depleted (Fig. 2C, middle and right
panels). Interestingly, we noted in these and other experiments
(Fig. 3A) that APLF migrates much more slowly than expected
during SDS-PAGE, at a position expected for a polypeptide of
75 kDa, most likely due to the acidic C-terminal tail.
The interactions of aprataxin and PNK with XRCC1 and
XRCC4 are greatly stimulated by the phosphorylation of the
latter proteins with CK2 (11, 16, 21, 22). To examine whether
this was true for APLF, we purified from E. coli full-length
histidine-tagged human His-APLF, an amino-terminal fragment
of His-APLF containing the FHA domain (His-APLF1-166),
and a C-terminal fragment of His-APLF (His-APLF360-511)
containing the putative C2H2 ZnFs (Fig. 3A). We then mock
phosphorylated or CK2 phosphorylated recombinant human
XRCC1-His in vitro and incubated the slot blotted products of
these reactions with recombinant His-APLF protein probes.
To confirm that XRCC1-His was successfully phosphorylated
by CK2, we employed two phospho-specific anti-XRCC1 anti-
bodies raised against the CK2 phosphorylation sites pS485/
pT488 and pS518/pS519/pS523 (Fig. 3B) (22). Whereas both
His-APLF and His-APLF1-166 preferentially interacted with
CK2-phosphorylated XRCC1-His (Fig. 3C, top left and middle
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FIG. 1. Conserved FHA and tandem ZnF domains in APLF. (A) Alignment of the FHA domains of APLF, aprataxin (APTX), and PNK.
Identical residues are in highlighted in red, highly conserved residues in blue, and similar residues in green. Putative phosphate-binding residues
are boxed in red, and the basic residues that are believed to confer specificity for binding CK2-phosphorylated motifs are underlined. (B) APLF
protein homologues. BLAST analyses identify multiple homologues of APLF in mouse (Mus musculus), chicken (Gallus gallus), mosquito
(Anopheles gambiae), and purple sea urchin (Strongylocentrotus purpuratus). Identical residues are in red, highly conserved residues in blue, and
blocks of similar residues in green. Dotted boxes denote the amino-terminal FHA domain and the putative tandem ZnFs at the C terminus.
(C) BLAST analyses with the C-terminal putative tandem ZnF motif of APLF identifies 18 additional polypeptides that possess this motif in single
copy, many of which are likely DNA repair- and DNA damage-associated proteins. Identical residues are boxed in yellow (note that these are the
putative metal coordinating residues), highly conserved residues boxed in green, and blocks of similar residues boxed in blue. Black circles denote
the C terminus of the polypeptide.
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panels), neither protein bound to control slots blotted with
CK2 reaction products lacking XRCC1-His (Fig. 3C, bottom
left panel). In contrast to His-APLF and His-APLF1-166, a
C-terminal fragment of His-APLF (His-APLF360-511) contain-
ing the putative C2H2 ZnFs failed to interact with CK2-phos-
phorylated XRCC1-His (Fig. 3C, right panel). Similar results
were observed by far-Western blotting, in which the CK2-
phosphorylated XRCC1-His protein probe detected His-
APLF and His-APLF1-166, but not His-APLF360-511, proteins
present on renatured Western blots (Fig. 3D). We conclude
from these experiments that the FHA domain in APLF inter-
acts with CK2-phosphorylated XRCC1.
To further examine whether APLF is a component of the
DNA damage response, we compared the subcellular localiza-
tion patterns of endogenous XRCC1 and APLF in human
A549 cells following UVA laser irradiation. As expected,
XRCC1 rapidly accumulated (within 3 min) at sites of UVA
damage (Fig. 4A). More significantly, APLF colocalized and
accumulated with XRCC1 at these sites, confirming that APLF
is a component of the response to UVA-induced cellular dam-
age. To examine the relationship between XRCC1 and APLF
in more detail, we compared the subcellular localization pat-
terns of YFP- and RFP-tagged human APLF and XRCC1
before and after treatment with H2O2 in transiently transfected
XRCC1 mutant CHO cells (EM9 cells). Whereas RFP-XRCC1
was largely or entirely nuclear in all transfected EM9 cells,
FIG. 2. Interaction of APLF with the DNA strand break repair proteins XRCC1 and XRCC4. (A) (Left) Yeast Y190 cells harboring
pGBKT7-APLF and the indicated pACT construct were plated onto selective media either containing histidine (Control) or lacking histidine and
containing 3-aminotriazole (His) to test for activation of the His3 reporter gene. The activation of the -Gal reporter gene was detected using filter
lifts from control plates containing histidine. (Right) Results of quantitative -Gal assays conducted on the Y190 cells described above. Data are
the means (	1 standard deviation) for three independent experiments. Expression levels of Myc-APLF (Gal4 binding domain fusion protein) and
the activation domain (AD) fusion proteins XRCC1 (X1), XRCC4 (X4), aprataxin (AX), and Lig3 (L3) in the yeast cultures employed for the
quantitative assays were determined by immunoblotting with anti-Myc or anti-Gal4 AD antibodies. Yeast cell extract from untransformed Y190
cells was included as an immunoblotting negative control (far right lane). Protein loading was assessed with Coomassie blue (C.Blue). (B) Levels
of XRCC1 and Myc-APLF proteins present in total cell extracts (inputs) and in anti-FLAG or anti-Myc immunoprecipitates (IP) from Myc-APLF
transiently transfected (HeLa/Myc-APLF) (top) or mock-transfected (HeLa) (bottom) HeLa cells. The position of Myc-APLF is indicated by an
arrow. The band visible above Myc-APLF is a contaminating antibody band. (C) (Left and middle) Levels of endogenous XRCC1 and APLF
present in total cell extracts (input) and in mouse IgG or anti-XRCC1 immunoprecipitates (IP) from A549 cells stably harboring empty pSuper
(A549) or the pSuper-APLF RNAi construct (A549/APLF KD). Note that XRCC1 was detected using both standard anti-XRCC1 (SK3188)
polyclonal antibody (top) and anti-phosphorylated XRCC1 (pS485/pT488) antibody (BL610; Bethyl Laboratories) (middle). APLF was detected
using the rabbit anti-APLF polyclonal antibody SK3595 (bottom). (Right) Immunoblot of total cell extracts from the A549 and A549/APLF KD
cell lines described above with SK3595 to demonstrate the specificity of this anti-APLF antibody.
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YFP-APLF was largely nuclear or pancellular in60% of cells
in the presence of RFP-XRCC1 and largely cytosolic or pan-
cellular in 90% of cells in the absence of RFP-XRCC1 (Fig.
4B and C, left panel). The fraction of cells with largely nuclear
YFP-APLF transiently increased after H2O2 treatment in an
RFP-XRCC1-dependent manner (Fig. 4C, middle and right
panels). The presence of a large proportion of cells with largely
nuclear YFP-APLF was also dependent on a functional FHA
domain, because the YFP-APLFR27A protein harboring a mu-
tated FHA domain was largely cytoplasmic or pancellular in
most cells both before and after H2O2 treatment, even in the
presence of RFP-XRCC1 (Fig. 4C). We conclude that RFP-
XRCC1 promoted the nuclear import or retention of YFP-
APLF in these experiments in a manner that was stimulated by
oxidative DNA damage and which required the APLF FHA
domain.
In the majority (83%) of cotransfected cells, YFP-APLF
and RFP-XRCC1 colocalized in subnuclear foci after H2O2
treatment (Fig. 4D and 5A, left panel). In contrast, far fewer
focus-positive cells (15%) were observed in EM9 cells trans-
fected with either YFP-APLF alone or a combination of YFP-
APLFR27A and RFP-XRCC1 (Fig. 5A). These data suggest
that RFP-XRCC1 stimulates the accumulation of YFP-APLF
at oxidative DNA strand breaks but that it is not essential for
this process. To examine whether this effect of RFP-XRCC1
reflected its impact on the nuclear localization of YFP-APLF, we
created YFP-nls-APLFR27A, a derivative of YFP-APLFR27A in
which we engineered an SV40 nuclear localization signal
FIG. 3. APLF preferentially interacts with CK2-phosphorylated XRCC1 in vitro. (A) One microgram of recombinant human His-APLF,
His-APLF1-166, or His-APLF360-511 was fractionated by SDS-PAGE and stained with Coomassie blue. (B) Aliquots of mock-phosphorylated (XH)
or CK2-phosphorylated (XH-P) recombinant human XRCC1-His were fractionated by SDS-PAGE and immunoblotted with anti-XRCC1
polyclonal antibody (SK3188) (XRCC1), anti-phosphoserine 485/phosphothreonine 488 XRCC1 polyclonal antibody (BL610; Bethyl Labs)
(pS485/pT488), or BL603 anti-phosphoserine 518/phosphothreonine 519/phosphothreonine 523 XRCC1 polyclonal antibody (BL603; Bethyl Labs)
(pS518/pT519/pT523). (C) Nitrocellulose membranes slot blotted with 1- to 8-l aliquots of phosphorylation reaction mixtures containing
XRCC1-His alone (0.125 to 1 g of XRCC1, respectively), CK2 alone, or both XRCC1-His (0.125 to 1 g) and CK2 (XRCC1-HisCK2) were
incubated with His-APLF, His-APLF1-166, or His-APLF360-511 protein probes, as indicated. Filter-bound APLF was then detected using anti-APLF
polyclonal antibody, which recognizes all three recombinant APLF proteins (data not shown). (D) Three micrograms of His-APLF, His-APLF1-166,
or His-APLF360-511 was fractionated by SDS-PAGE in quadruplicate, transferred to nitrocellulose, renatured, and incubated with protein probes
comprised of mock phosphorylation reaction mixtures containing XRCC1-His protein alone (XRCC1), CK2 phosphorylation reaction mixtures
containing XRCC1-His and CK2 (XRCC1/CK2), or CK2 phosphorylation reaction mixtures lacking XRCC1-His (CK2). The fourth replicate was
stained with Ponceau S. Filter-bound XRCC1-His was subsequently detected using anti-XRCC1 antibody.
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(NLS). As expected, YFP-nls-APLFR27A was largely or en-
tirely nuclear and, moreover, accumulated extensively at oxi-
dative DNA strand breaks (Fig. 5A, right panel). These data
suggest that XRCC1 facilitates the accumulation of APLF at
oxidative SSBs by promoting the nuclear import of APLF, in
part at least.
In contrast to RFP-XRCC1, RFP-XRCC4 did not form
measurable subnuclear foci after H2O2 and had little or no
effect on the subcellular localization of YFP-APLF when ex-
pressed in XRCC4 mutant XR-1 CHO cells (data not shown).
However, we did note that large numbers (40%) of XR-1
cells possessed YFP-APLF or YFP-APLFR27A foci after H2O2
treatment (data not shown). This most likely reflects the
XRCC1-independent recruitment/accumulation of recombi-
nant APLF at DNA strand breaks that was observed, albeit to
a lesser extent, in EM9 cells. We considered the possibility that
the XRCC1-independent recruitment/accumulation of APLF
at sites of oxidative DNA damage might be mediated via the
putative C2H2 ZnF motifs. To examine this possibility, we
expressed derivatives of APLF in which the two putative zinc
coordinating cysteine residues in the first (YFP-APLFzfm1) or
second (YFP-APLFzfm2) ZnF were mutated to alanine. Nei-
ther of the ZnF mutations reduced XRCC1-dependent nuclear
import/retention of YFP-APLF in untreated EM9 cells, al-
though the ZFM1 mutation did reduce the XRCC1-dependent
increase in nuclear YFP-APLF observed after H2O2 treatment
(Fig. 5B, right panel). The ZFM1 mutation also reduced the
formation of YFP-APLF nuclear foci in the presence of
XRCC1, by 30% (Fig. 5C, left panel). More significantly,
however, the XRCC1-independent accumulation of YFP-APLF
in nuclear foci was reduced by the ZFM2 mutation and ablated
by the ZNF1 mutation (Fig. 5C, right panel). These data con-
firm that the tandem ZnF motif is required for XRCC1-inde-
pendent recruitment/accumulation of APLF at sites of oxidative
DNA strand breakage.
To examine whether the tandem ZnF promoted XRCC1-
independent accumulation of YFP-APLF at sites of oxidative
DNA damage through an impact on nuclear localization, we
employed derivatives of YFP-APLF and YFP-APLFZnF1 that
harbored an SV40 NLS, denoted YFP-nls-APLF and YFP-nls-
APLFZnF1, respectively. While both YFP-nls-APLF and YFP-
nls-APLFZnF1 were able to assemble into subnuclear foci in
the presence of XRCC1, only YFP-nls-APLF did so in the
absence of RFP-XRCC1 (Fig. 5D, left and middle panels).
Thus, the addition of an NLS did not circumvent the require-
ment for the tandem ZnF, suggesting that the ZnF fulfills a
function other than increasing the nuclear import/retention of
YFP-APLF. Interestingly, we noted in these experiments that
RFP-XRCC1 stimulated the assembly of YFP-nls-APLF nu-
clear foci, despite the presence of an NLS, and did so in a
manner that was dependent on an intact FHA domain (Fig.
5D, middle and right panels). This suggests that the impact of
the XRCC1-APLF interaction extends beyond its ability to
promote APLF nuclear import/retention. In summary, we con-
clude from these experiments that the accumulation of YFP-
APLF at oxidative DNA strand breaks is promoted by at least
three mechanisms: two that are dependent on FHA domain-
mediated interaction with XRCC1, including one that involves
increased nuclear import/retention of APLF, and one that is
FIG. 4. XRCC1 promotes DNA damage-associated subcellular re-
distribution of APLF. (A) Indirect immunofluorescence analysis of
endogenous XRCC1 and APLF accumulation at sites of UVA irradi-
ation. Human A549 cells were preincubated with Hoechst 33258 (10
g/ml) for 10 min and irradiated within the area indicated (left panel,
dotted white box) with a UVA laser (351 nm). Three minutes after
exposure, cells were fixed and labeled with mouse anti-XRCC1 MAb
and rabbit anti-APLF SK3595 polyclonal antibody, followed by goat
Alexa Fluor 555-conjugated anti-mouse (red) and goat Alexa Fluor
488-conjugated anti-rabbit (green) secondary antibodies. DNA was
counterstained with DAPI (blue). (B) Subcellular localization of YFP-
APLF protein transiently expressed alone or in combination with RFP-
XRCC1 in XRCC1 mutant EM9 CHO cells. Note that the images
included here depict cells with largely nuclear (top) or largely cyto-
plasmic (bottom) YFP-APLF. (C) Quantitation of the fraction of tran-
siently transfected HeLa cells expressing YFP-APLF or YFP-
APLFR27A alone (
) or in combination with RFP-XRCC1 (X1) in
which the recombinant APLF is largely nuclear (nc), largely cytoplas-
mic (cy), or pancellular (pc). Prior to analysis, cells were either un-
treated or treated, as indicated, with 10 mM H2O2 for 10 min, followed
by 20 min or 2 h in drug-free medium to allow recovery. (D) Subcel-
lular localization of YFP-APLF protein transiently expressed alone or
in combination with RFP-XRCC1 in H2O2-treated XRCC1 mutant
EM9 CHO cells.
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independent of XRCC1 but dependent on the tandem ZnF
motif.
To further examine the involvement of APLF in the re-
sponse to DNA damage, we compared its electrophoretic mo-
bilities before and after treatment with gamma rays or H2O2.
Notably, the mobility of endogenous APLF during SDS-PAGE
decreased after treatment with either H2O2 or ionizing radia-
tion (IR) in wild-type cells and in aprataxin-defective AOA1
primary fibroblasts (Fig. 6A). However, this shift in electro-
phoretic mobility was not detected in ataxia telangiectasia fi-
broblasts lacking the DSB-responsive protein kinase ATM.
These data support the idea that APLF is involved in the
cellular response to DSBs. To examine whether APLF is re-
quired for chromosomal DNA single- and double-strand break
repair, we mock depleted or depleted APLF or XRCC1 from
differentiated/noncycling SH-SY5Y neuroblastoma cells by
transient siRNA transfection (Fig. 6B, left panel). Whereas the
type of siRNA did not affect the level of DNA strand breaks
induced by IR, as measured by alkaline comet assays, the rate
at which DNA strand breaks declined was significantly delayed
in both XRCC1- and APLF-depleted cells (Fig. 6C). It is likely
that the delay observed here reflects a defect in SSBR, because
95% of the total breaks induced by IR are SSBs (4). To
examine the rate of DSBR, we quantified the level of -H2AX,
an established marker of DSBs (26, 27), in gamma ray-treated
SH-SY5Y neuroblastoma cells that were depleted of APLF as
described above or in A549 cells that were stably depleted of
APLF (Fig. 5B, right panels). We consistently observed in
these experiments that -H2AX foci declined at significantly
reduced rates in both APLF-depleted neuroblastoma cells and
A549 cells following 1 to 3 Gy of IR (Fig. 6D). In contrast,
repair rates were normal in XRCC1-depleted SH-SY5Y cells,
consistent with the absence of a measurable DSBR defect in
these cells (Fig. 6D, right panel).
FIG. 5. A novel tandem ZnF motif in APLF mediates XRCC1-independent recruitment/accumulation at sites of oxidative DNA damage.
(A) Quantification of the fraction of untreated (open bars) and H2O2-treated (filled bars) XRCC1 mutant EM9 CHO cells containing YFP-APLF
(APL), YFP-APLFR27A (APLR27A), or YFP-nls-APLFR27A (nls-APLR27A) nuclear foci in the presence (X1) or absence (
) of cotransfected
mRFP-XRCC1. All data are the means (	1 standard error) for three or more independent experiments. Confirmation of the complete nuclear
localization of YFP-nls-APLFR27A is shown on the right. (B) Quantitation of the fraction of transiently transfected HeLa cells coexpressing
RFP-XRCC1 and YFP-APLF (APLX1), YFP-APLFzfm1 (APLzfm1X1), or YFP-APLFzfm2 (APLzfm2X2) in which the recombinant APLF is
largely nuclear (nc), largely cytoplasmic (cy), or pancellular (pc). Prior to analysis, cells were either untreated or treated, as indicated, with 10 mM
H2O2 for 10 min, followed by 20 min in drug-free medium to allow repair. (C) Quantitation of the fraction of transiently transfected HeLa cells
with YFP-APLF (APL), YFP-APLFzfm1 (APLzfm1), or YFP-APLFzfm2 (APLzfm2) subnuclear foci in the presence (left) or absence (right) of
cotransfected RFP-XRCC1 (X1). Prior to analysis, cells were either untreated or treated, as indicated, with 10 mM H2O2 for 10 min, followed by
20 min or 2 h in drug-free medium to allow recovery. (D) Quantitation of the fraction of transiently transfected HeLa cells with YFP-nls-APLF
(nls-APLF), YFP-nls-APLFzfm1 (nls-APLFzfm1), or YFP-nls-APLFR27A (nls-APLFR27A) subnuclear foci in the presence () or absence (
) of
cotransfected RFP-XRCC1. Prior to analysis, cells were either untreated or treated, as indicated, with 10 mM H2O2 for 10 min, followed by 20
min or 2 h in drug-free medium to allow recovery.
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We describe here a new component of the DNA single- and
double-strand break repair machinery. This protein is a previ-
ously uncharacterized ORF (C2orf13) that we have denoted
APLF based on the presence of an aprataxin- and PNK-like
FHA domain at its amino terminus. Consistent with the pres-
ence of this domain, APLF interacts with both XRCC1 and
XRCC4, the same components of the single- and double-
strand break repair machinery that are bound by PNK and
aprataxin (11, 12, 14, 16, 22, 33). Moreover, similar to the
situation with PNK and aprataxin, the interaction of XRCC1
with full-length APLF in vitro or with a fragment of APLF
containing the FHA domain was largely dependent on the
phosphorylation of XRCC1 by CK2. Intriguingly, a yeast two-
hybrid screen employing APLF as bait recovered not only
multiple clones of both XRCC1 and XRCC4 but also multiple
clones of XRCC5 (Ku86). Of 109 cDNA clones recovered, 6
encoded XRCC1, 15 encoded XRCC4, and 7 encoded XRCC5
(Ku86) (data not shown). APLF may thus associate with the
nonhomologous end-joining machinery through interactions
with both XRCC4 and the Ku86 heterodimer.
Direct evidence of a role for APLF in the cellular response
to DNA damage emerged from the observations that endoge-
nous APLF accumulates at sites of UVA laser damage in
human A549 cells and that recombinant YFP-APLF accumu-
lates in subnuclear foci in H2O2-treated CHO cells. Whereas
the UVA laser tracts most likely contain sites with both single-
and double-strand breaks (data not shown), the H2O2-induced
foci most likely reflect just SSBs. This is because they colocal-
ize and are stimulated by RFP-XRCC1 and because they do
FIG. 6. Delayed rates of DNA strand break repair in APLF-depleted human cells. (A) Comparison of the electrophoretic mobilities of endogenous
APLF in normal, ataxia telangiectasia (A-T), and AOA1 primary human fibroblasts before and after treatment with either gamma rays (3 Gy) (left) or
10 mM H2O2 for 10 min (right), followed by recovery in drug-free medium for 20 to 30 min. APLF was detected by immunoblotting with anti-APLF
SK3595 polyclonal antibody. (B) Cell extracts from quiescent SH-SY5Y neuroblastoma cells mock transfected or transiently transfected with XRCC1 or
APLF siRNA (left) or from cycling A549 cells stably transfected with empty pSuper vector (WT) or the pSuper APLF knockdown construct (clones 5
and 6 [cl5 and cl6]) (right) were immunoblotted for levels of XRCC1, APLF, and actin as indicated. (C) Quantitation of DNA strand breakage, as
measured by alkaline comet assays, in untreated quiescent SH-SY5Y neuroblastoma cells or in irradiated (20 Gy of gamma rays) cells following a
subsequent incubation for the indicated periods to allow time for repair. Cells were mock transfected or transiently transfected with XRCC1 or APLF
siRNA prior to irradiation. In each experiment, the average tail moment for 100 cells per sample was calculated and the plotted data are the means (	1
standard error) for four independent experiments. (D) (Left and middle) Quantitation of DNA double-strand breakage, as measured by -H2AX assays,
in cycling A549 cells stably transfected with empty pSuper vector (WT) or pSuper APLF knockdown construct (KD) (cl5) after 1 to 3 Gy (left) or 2 Gy
(middle) of gamma rays, followed by incubation for the indicated periods (30 to 120 min) to allow time for DNA repair. The mean number of gamma
ray-induced -H2AX foci per cell is plotted, and the data are from a single experiment in the left panel and are the means for three independent
experiments in the middle panel. (Right) Quantitation of DNA double-strand breakage, as measured by -H2AX assays, in quiescent SH-SY5Y cells after
-irradiation (2 Gy), followed by a subsequent repair/incubation for 15 to 120 min. Cells were either mock transfected or transiently transfected with
XRCC1 or APLF siRNA prior to irradiation. The mean number of -H2AX foci per cell is plotted, and the data are the means for three independent
experiments. Note that in the -H2AX experiments, less than one focus per cell was visible prior to, or immediately after, irradiation. Asterisks denote
statistical significance (paired t test) with wild-type or mock-depleted cells. *, P  0.05; **, P  0.01.
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not significantly colocalize with sites of -H2AX (data not
shown). In addition, we failed to detect accumulation of the
DSBR protein XRCC4 in H2O2-induced subnuclear foci under
the same experimental conditions. It is also noteworthy that, in
collaborative experiments with Akira Yasui, we observed the
accumulation of YFP-APLF at UVA laser-induced damage
under conditions where SSBs are selectively induced (19; un-
published observations).
The ability of RFP-XRCC1 to stimulate the accumulation of
YFP-APLF in subnuclear foci most likely reflected, at least in
part, the impact of recombinant XRCC1 on the nuclear import
or retention of YFP-APLF. This is because the addition of an
NLS to YFP-APLF circumvented the requirement of RFP-
XRCC1 for high levels of YFP-APLF nuclear foci. However,
these experiments do not rule out an additional role(s) for
XRCC1 during the accumulation of YFP-APLF at sites of
DNA damage. This is because the NLS had a much greater
impact on the nuclear import/retention of YFP-APLF than did
recombinant RFP-XRCC1, perhaps thereby masking addi-
tional roles for XRCC1. Indeed, consistent with this notion,
the coexpression of RFP-XRCC1 stimulated the appearance
of YFP-nls-APLF nuclear foci, albeit to a lesser extent than
YFP-APLF foci (fivefold versus twofold), despite the presence
of an NLS. The nature of the alternative mechanism by which
XRCC1 might promote the accumulation of YFP-APLF at
sites of oxidative DNA damage is not known. However, since
this mechanism required an intact FHA domain in APLF, one
attractive possibility is that it reflects the scaffolding role of
XRCC1. A similar explanation has been suggested for the
observation that XRCC1 also promotes the accumulation of
aprataxin, PNK, and DNA polymerase  at sites of H2O2-
induced DNA damage (21; unpublished observations).
H2O2-induced YFP-APLF foci were observed in 15 to 40%
of CHO cells in the absence of XRCC1, and a similar fraction
of YFP-APLF focus-positive cells was observed when RFP-
XRCC1 was coexpressed with YFP-APLF lacking an intact
FHA domain. Thus, although greatly stimulated by the coex-
pression of recombinant XRCC1, the recruitment/accumula-
tion of YFP-APLF at sites of oxidative DNA damage can occur
independent of XRCC1. Intriguingly, this XRCC1-indepen-
dent mode of APLF recruitment/accumulation required the
two tandem ZnF motifs, supporting the notion that these struc-
tures represent a novel class of DNA strand break-responsive
motifs. The amino acid sequences of the tandem ZnFs in
APLF appear to be distinct from those present in other SSBR/
DSBR proteins, such as aprataxin and poly(ADP-ribose) poly-
merase 1, as indicated by the limited number of proteins de-
tected as containing this motif in database searches (Fig. 1C).
It is not yet clear what function these putative ZnFs fulfill, but
the presence of this structure in a variety of other DNA repair
and DNA metabolic proteins suggests that it is an important
one. The impact of the ZnFs on the XRCC1-independent
recruitment/accumulation of YFP-APLF at sites of oxidative
DNA damage was not mediated via increased nuclear import
or retention of APLF, because the addition of an NLS did not
compensate for the absence of intact ZnFs. We suggest that
the ZnF may bind to DNA strand breaks directly, thereby
promoting XRCC1-independent recruitment of APLF at sites
of chromosomal damage.
In contrast to RFP-XRCC1, RFP-XRCC4 did not promote
the redistribution of APLF to nuclei or the accumulation of
APLF in H2O2-induced subnuclear foci. This may reflect the
nature of the cellular response to DSBs because accumula-
tion in discrete subnuclear foci does not appear to be a
general feature of nonhomologous end-joining enzymes such
as XRCC4 and Ku following oxidative stress. However, further
evidence that APLF is involved in the response to DSBs was
suggested by the change in the electrophoretic mobility of this
protein induced by IR or H2O2. Significantly, this phenomenon
was dependent on the DSB sensor protein kinase ATM, sug-
gesting that APLF is phosphorylated in an ATM-dependent
manner in response to DSBs, though we cannot rule out that
ATM is activated in this context by some other type of lesion
or event. It also remains to be determined whether APLF is a
substrate for ATM or whether APLF is modified via ATM
indirectly.
Alkaline comet and -H2AX assays suggested that the de-
pletion of APLF by siRNA retards the rate of DNA single- and
double-strand break repair at early times after IR. We ob-
served a DSBR defect in both proliferating A549 lung carci-
noma cells and noncycling SH-SY5Y neuroblastoma cells, as
measured by -H2AX staining. However, using alkaline comet
assays, we detected a DNA strand break repair defect only in
noncycling SH-SY5Y cells (data not shown). Since alkaline
comet assays measured primarily SSBs in these experiments,
due to the abundance of SSBs relative to DSBs induced by IR
(20:1), we suggest that this reflects a difference in the redun-
dancies of APLF during SSBR in proliferating versus non-
cycling cells. Differences in polypeptide requirements during
SSBR in S-phase versus nonreplicating cells have been re-
ported previously (24, 29). The impact of APLF depletion on
DNA strand break repair rates was subtle, though in the case
of SSBR, it was no less subtle than in cells depleted of XRCC1,
which is the archetypal SSBR protein (7, 32). The relatively
small impact on repair rates observed in these experiments
could thus be due to the incomplete depletion of XRCC1 and
APLF by siRNA. Alternatively, it is possible that APLF is
required for the rapid repair of only a subset of DNA strand
breaks, such as those with specific types of DNA termini. This
is also most likely the case for aprataxin, which removes rare 5
AMP adducts from DNA strand breaks in vitro but does not
have a measurable impact on global rates of DNA strand break
repair in vivo (1).
What role might APLF play during DNA strand break re-
pair? Given that APLF most likely binds the same regions of
XRCC1 and XRCC4 that are bound by PNK and aprataxin,
both of which are end processing enzymes, it is tempting to
speculate that APLF fulfills or facilitates a similar activity. This
suggests a model in which CK2-phosphorylated XRCC1 or
XRCC4 can recruit one of at least three different end process-
ing activities to an SSB or DSB, depending on the nature of the
damaged termini. The unusual nature of the tandem ZnFs may
be informative in this respect. Combined sequence/structure
database analyses assign this motif as a tandem ZnF most
closely related to the CCCH tandem ZnFs present in the
tristetrapolin family of mRNA binding proteins (3, 17). Inter-
estingly, these tandem ZnFs appear to be required to facilitate
the deadenylation of 3 poly(A) tails of specific mRNAs, most
likely through the recruitment of an RNase (18). Although
they share some similarities, the APLF tandem ZnFs and
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tristetraprolin family ZnFs are clearly distinct, most notably in
the spacing between the zinc coordinating residues and the
absence of specific residues critical for mRNA binding. It is
thus tempting to speculate that the tandem putative ZnFs in
APLF target DNA rather than RNA, thereby facilitating the
processing of a specific type of DNA 3 terminus.
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Biochemistry Department, Faculty of Pharmacy, Aim Shams University, P.O. Box 11566, Cairo, Egypt
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